238 related articles for article (PubMed ID: 21489839)
1. Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia.
Silva DG; Belini Junior E; Torres Lde S; Ricci Júnior O; Lobo Cde C; Bonini-Domingos CR; de Almeida EA
Blood Cells Mol Dis; 2011 Jun; 47(1):23-8. PubMed ID: 21489839
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, and GSTP1) in Egyptian pediatric patients with sickle cell disease.
Shiba HF; El-Ghamrawy MK; Shaheen IA; Ali RA; Mousa SM
Pediatr Dev Pathol; 2014; 17(4):265-70. PubMed ID: 24840051
[TBL] [Abstract][Full Text] [Related]
3. Serum melatonin level and oxidative stress in sickle cell anemia.
Shimauti EL; Silva DG; de Almeida EA; Zamaro PJ; Belini Junior E; Bonini-Domingos CR
Blood Cells Mol Dis; 2010 Dec; 45(4):297-301. PubMed ID: 20888275
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and antioxidant capacity in sickle cell anaemia patients receiving different treatments and medications for different periods of time.
Belini Junior E; da Silva DG; Torres Lde S; de Almeida EA; Cancado RD; Chiattone C; Bonini-Domingos CR
Ann Hematol; 2012 Apr; 91(4):479-89. PubMed ID: 21947087
[TBL] [Abstract][Full Text] [Related]
5. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
[TBL] [Abstract][Full Text] [Related]
6. Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia.
Silva DG; Belini Junior E; Carrocini GC; Torres Lde S; Ricci Júnior O; Lobo CL; Bonini-Domingos CR; de Almeida EA
BMC Med Genet; 2013 Oct; 14():108. PubMed ID: 24106994
[TBL] [Abstract][Full Text] [Related]
7. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
[TBL] [Abstract][Full Text] [Related]
8. Sickle Cell Anemia Patients in Use of Hydroxyurea: Association between Polymorphisms in Genes Encoding Metabolizing Drug Enzymes and Laboratory Parameters.
Yahouédéhou SCMA; Carvalho MOS; Oliveira RM; Santiago RP; da Guarda CC; Carvalho SP; Ferreira JRD; Aleluia MM; Adorno EV; Gonçalves MS
Dis Markers; 2018; 2018():6105691. PubMed ID: 29619129
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
Vicari P; Barretto de Mello A; Figueiredo MS
Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
[TBL] [Abstract][Full Text] [Related]
10. Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease.
Lakhdar R; Denden S; Mouhamed MH; Chalgoum A; Leban N; Knani J; Lefranc G; Miled A; Ben Chibani J; Khelil AH
Exp Lung Res; 2011 May; 37(4):195-204. PubMed ID: 21309732
[TBL] [Abstract][Full Text] [Related]
11. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.
Lanzkron S; Haywood C; Segal JB; Dover GJ
Am J Hematol; 2006 Dec; 81(12):927-32. PubMed ID: 16924648
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
Sumoza A; de Bisotti R; Sumoza D; Fairbanks V
Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
[TBL] [Abstract][Full Text] [Related]
13. The role of glutathione S- transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension.
Bessa SS; Ali EM; Hamdy SM
Eur J Intern Med; 2009 Oct; 20(6):625-30. PubMed ID: 19782926
[TBL] [Abstract][Full Text] [Related]
14. Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients.
Silva-Pinto AC; Dias-Carlos C; Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Elion J; Covas DT; Zago MA; Panepucci RA
Ann Hematol; 2014 Sep; 93(9):1457-65. PubMed ID: 24696091
[TBL] [Abstract][Full Text] [Related]
15. Influence of βS allele in the lipid peroxidation and antioxidant capacity parameters.
Shimauti EL; Belini Junior E; Baracioli LM; Souza EM; Granzotto D; Almeida EA; Silva DG; Ricci Junior O; Bonini-Domingos CR
Int J Lab Hematol; 2014 Apr; 36(2):205-12. PubMed ID: 24118969
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
Charache S
Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
[TBL] [Abstract][Full Text] [Related]
17. DNA damage in leukocytes of sickle cell anemia patients is associated with hydroxyurea therapy and with HBB*S haplotype.
da Silva Rocha LB; Dias Elias DB; Barbosa MC; Bandeira IC; Gonçalves RP
Mutat Res; 2012 Dec; 749(1-2):48-52. PubMed ID: 22918118
[TBL] [Abstract][Full Text] [Related]
18. Effect of hydroxyurea on the deformability of the red blood cell membrane in patients with sickle cell anemia.
Athanassiou G; Moutzouri A; Kourakli A; Zoumbos N
Clin Hemorheol Microcirc; 2006; 35(1-2):291-5. PubMed ID: 16899945
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea treatment of sickle cell anemia in hospital-based practices.
Ferguson RP; Arun A; Carter C; Walker SD; Castro O
Am J Hematol; 2002 Aug; 70(4):326-8. PubMed ID: 12214583
[TBL] [Abstract][Full Text] [Related]
20. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
